The Effects of a Single Dose of Wild Blueberries on Mood and Cognition in Healthy Young Adults
1 other identifier
interventional
33
1 country
1
Brief Summary
This study aims to investigate whether consuming a drink containing powdered blueberries (equivalent to 150 g fresh fruit) can improve mood and cognition in healthy young adults. Blood biomarkers of inflammation and neurotransmitter turnover will be analyzed as well as responses to computer-based cognitive tasks designed to measure verbal memory, executive function, and emotional processing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 26, 2021
CompletedFirst Submitted
Initial submission to the registry
May 27, 2021
CompletedFirst Posted
Study publicly available on registry
June 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2021
CompletedSeptember 21, 2021
September 1, 2021
3 months
May 27, 2021
September 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Global transient mood as measured by PANAS-X
The Positive and Negative Affect Schedule - Expanded Form (PANAS-X) is a validated, self-rated measure of affective state, encompassing two general dimensions (positive and negative affect). These will be calculated separately by adding the values of the individual items (21 positive and 25 negative items). Thus, the scales will range from 0 to 84 points for positive affect and from 0 to 100 for negative affect, with a higher score indicating greater positive or negative affect. Positive affect will be considered the primary measure.
baseline
Global transient mood as measured by PANAS-X
The Positive and Negative Affect Schedule - Expanded Form (PANAS-X) is a validated, self-rated measure of affective state, encompassing two general dimensions (positive and negative affect). These will be calculated separately by adding the values of the individual items (21 positive and 25 negative items). Thus, the scales will range from 0 to 84 points for positive affect and from 0 to 100 for negative affect, with a higher score indicating greater positive or negative affect. Positive affect will be considered the primary measure
2 hours post-ingestion
Negative interpretation bias
A negative interpretation bias is defined as a tendency to interpret ambiguous information in a consistently threatening or negative manner, thus serving as an objective indicator of affective state. In this task, participants will be asked to categorize facial expressions of anger, happiness, and surprise as either positive or negative. Interpretation bias will be operationalized as the percent of trials in which surprised faces were rated as negative, out of the total number of surprise trials (48 trials).
baseline
Negative interpretation bias
A negative interpretation bias is defined as a tendency to interpret ambiguous information in a consistently threatening or negative manner, thus serving as an objective indicator of affective state. In this task, participants will be asked to categorize facial expressions of anger, happiness, and surprise as either positive or negative. Interpretation bias will be operationalized as the percent of trials in which surprised faces were rated as negative, out of the total number of surprise trials (48 trials).
2 hours post-ingestion
Cognitive flexibility (accuracy on post-switch trials)
A task-switching test will be used to assess cognitive performance when switching between two predictable tasks requiring simple numerical decisions. The main outcome of interest is the average accuracy of responses to post-switch trials (those immediately following a switch to a new task).
baseline
Cognitive flexibility (accuracy on post-switch trials)
A task-switching test will be used to assess cognitive performance when switching between two predictable tasks requiring simple numerical decisions. The main outcome of interest is the average accuracy of responses to post-switch trials (those immediately following a switch to a new task).
2 hours post-ingestion
Delayed verbal memory on RAVLT
The Rey Auditory Verbal Learning Test (RAVLT) is a standard neuropsychological assessment designed to evaluate verbal memory. The participant hears a list of 15 words and is asked to recall as many words as possible. This procedure is repeated five times. The main outcome of interest is the number of correctly recalled words 20 minutes after the last presentation of the list of words (Trial A7).
baseline
Delayed verbal memory on RAVLT
The Rey Auditory Verbal Learning Test (RAVLT) is a standard neuropsychological assessment designed to evaluate verbal memory. The participant hears a list of 15 words and is asked to recall as many words as possible. This procedure is repeated five times. The main outcome of interest is the number of correctly recalled words 20 minutes after the last presentation of the list of words (Trial A7).
2 hours post-ingestion
Serum brain-derived neurotrophic factor (BDNF)
Serum levels of BDNF will be analyzed using enzyme-linked immunosorbent assay (ELISA).
baseline
Serum brain-derived neurotrophic factor (BDNF)
Serum levels of BDNF will be analyzed using enzyme-linked immunosorbent assay (ELISA).
2 hours post-ingestion
Secondary Outcomes (34)
Distinct affective states as measured by PANAS-X subscales
baseline
Distinct affective states as measured by PANAS-X subscales
2 hours post-ingestion
Reaction time to positive stimuli
baseline
Reaction time to positive stimuli
2 hours post-ingestion
Reaction time to negative stimuli
baseline
- +29 more secondary outcomes
Other Outcomes (2)
Recognition memory on RAVLT
baseline
Recognition memory on RAVLT
2 hours post-ingestion
Study Arms (2)
Blueberry/Placebo
EXPERIMENTALIn this arm, participants will receive the blueberry intervention first, followed by the placebo one week later.
Placebo/Blueberry
EXPERIMENTALIn this arm, participants will receive the placebo first, followed by the blueberry intervention one week later.
Interventions
22 g freeze-dried wild blueberry (Vaccinium angustifolium) powder, mixed with 250 ml water, and served in an opaque container.
22 g placebo powder matched for macronutrients and flavor, mixed with 250 ml water, and served in an opaque container.
Eligibility Criteria
You may qualify if:
- to 25 years of age
- Willingness to provide blood samples
You may not qualify if:
- Allergy to blueberries or any other Vaccinium species
- Diagnosis or symptoms of anxiety, depression, or other mental health conditions
- Any medically significant condition (e.g. anemia, gastrointestinal disorders, diabetes)
- Use of psychoactive medication or recreational drugs in the last two weeks
- Current use of medication that could interact with the intervention (e.g. antibiotics)
- Obesity or underweight
- Participation in other interventional studies in the last month
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Readinglead
- Wild Blueberry Association of North Americacollaborator
Study Sites (1)
School of Psychology and Clinical Languages, University of Reading
Reading, Berkshire, RG6 6AL, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 27, 2021
First Posted
June 22, 2021
Study Start
May 26, 2021
Primary Completion
August 27, 2021
Study Completion
August 27, 2021
Last Updated
September 21, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP